Cochrane · systematic review · CD003483
Naloxone for opioid‐exposed newborn infants
Moe‐Byrne, T, Brown, JVE, McGuire, W · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
NeonatalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
0
No studies
6
Included studies
NR
No studies 6 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Naloxone compared to placebo or no drug for opiate‐exposed newborn infants
Population: opioid‐exposed newborn infants
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Admission to neonatal intensive or special care unit ‐ not reported Naloxone vs placebo or no drug | no estimate extracted | NR | No studies |
Duration of neonatal intensive or special care unit stay ‐ not reported Naloxone vs placebo or no drug | no estimate extracted | NR | No studies |
Failure to establish breastfeeding prior to hospital discharge ‐ not reported Naloxone vs placebo or no drug | no estimate extracted | NR | No studies |
Neurodevelopmental outcomes beyond infancy ‐ not reported Naloxone vs placebo or no drug | no estimate extracted | NR | No studies |
Receipt of endotracheal intubation ‐ not reported Naloxone vs placebo or no drug | no estimate extracted | NR | No studies |
Receipt of assisted ventilation ‐ not reported Naloxone vs placebo or no drug | no estimate extracted | NR | No studies |